scholarly article | Q13442814 |
P356 | DOI | 10.1002/AJMG.1328 |
P698 | PubMed publication ID | 11353440 |
P50 | author | Joseph Biederman | Q6281524 |
Stephen Faraone | Q7609174 | ||
Jordan W Smoller | Q57394220 | ||
Snidman N | Q125312526 | ||
P2093 | author name string | Tsuang MT | |
Kennedy J | |||
Rosenbaum JF | |||
Schwarz A | |||
Kagan J | |||
Slaugenhaupt SA | |||
Laird N | |||
Susswein LS | |||
P2860 | cites work | Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor | Q24323906 |
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin | Q28505477 | ||
The future of genetic studies of complex human diseases | Q29547215 | ||
Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10 | Q33412441 | ||
Distribution, biochemistry and function of striatal adenosine A2A receptors | Q33740841 | ||
Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions | Q34145152 | ||
Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. | Q34471162 | ||
Biological Bases of Childhood Shyness | Q34687549 | ||
Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. | Q35010483 | ||
The relationship between panic disorder and major depression. A new family study | Q36753238 | ||
Tests for emotionality in rats and mice: A review | Q39929089 | ||
Fear and Fearfulness in Animals | Q40443699 | ||
The adenosine A(2A) receptor knockout mouse: a model for anxiety? | Q40715903 | ||
Panic disorder in women: a population-based twin study | Q40825835 | ||
Regulation of gamma-aminobutyric acid synthesis in the brain | Q40868545 | ||
Genetics of complex disease: approaches, problems, and solutions | Q40879181 | ||
Neurobiologic basis of anxiety and its treatment | Q41062055 | ||
Behavioral inhibition in childhood: a risk factor for anxiety disorders | Q41652518 | ||
Anxiolytic activity of adenosine receptor activation in mice | Q41771392 | ||
Linkage and association studies in insulin-dependent diabetes with a new dinucleotide repeat polymorphism at the GAD65 locus | Q42633118 | ||
A simple genetic basis for a complex psychological trait in laboratory mice | Q43326381 | ||
Familial transmission of simple phobias and fears. A preliminary report | Q43627919 | ||
Relationship between panic disorder and agoraphobia. A family study | Q43970819 | ||
The genetics of six neurotic disorders: a twin study | Q44534736 | ||
Comorbidity of parental anxiety disorders as risk for childhood-onset anxiety in inhibited children | Q44571021 | ||
The genetic epidemiology of phobias in women. The interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia | Q44906917 | ||
Two isoforms of glutamate decarboxylase: why? | Q45345778 | ||
Changes in nociceptive and anxiolytic responses following herpes virus-mediated preproenkephalin overexpression in rat amygdala are naloxone-reversible and transient | Q45748264 | ||
A direct-interview family study of generalized social phobia | Q46109745 | ||
The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children | Q47818285 | ||
Mapping quantitative trait loci for open-field behavior in mice | Q48752488 | ||
Differences in fear motivated behaviors among inbred mouse strains | Q48824455 | ||
Behavioral and physiological antecedents of inhibited and uninhibited behavior | Q49044339 | ||
Freeze! | Q51100645 | ||
Behavioral and neuroendocrine responses in shy children. | Q51105575 | ||
Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. | Q51130540 | ||
Genetic change and continuity from fourteen to twenty months: the MacArthur Longitudinal Twin Study. | Q51139914 | ||
Exclusion of the tyrosine hydroxylase gene in 14 panic disorder pedigrees. | Q51165378 | ||
Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. | Q51171080 | ||
Quality of life in panic disorder. | Q51173601 | ||
Children's behavioral inhibition over age and across situations: genetic similarity for a trait during change. | Q51176146 | ||
Pro-opiomelanocortin (POMC) gene excluded as a cause of panic disorder in a large family. | Q51204898 | ||
Genetic factors in anxiety disorders. | Q51239731 | ||
A family study of panic disorder. | Q51239742 | ||
Investigation of cholecystokinin system genes in panic disorder. | Q51983515 | ||
A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. | Q52079461 | ||
Behavioural inhibition, attachment and anxiety in children of mothers with anxiety disorders. | Q52209668 | ||
The physiology and psychology of behavioral inhibition in children. | Q52254177 | ||
Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders. | Q52569629 | ||
Results of a genome-wide genetic screen for panic disorder | Q57150701 | ||
High-resolution mapping of quantitative trait loci in outbred mice | Q57234034 | ||
Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder | Q57655561 | ||
Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease | Q57655621 | ||
Neuronal nicotinic acetylcholine receptor α4 subunit (CHRNA4) and panic disorder: An association study | Q57655643 | ||
Mapping of the human adenosine A 2a receptor gene: relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region | Q57655649 | ||
Panic attacks: a twin study | Q60441458 | ||
Physiological and behavioral responses to minor stressors in offspring of patients with panic disorder | Q60626536 | ||
Adrenergic receptor genes as candidate genes for panic disorder: a linkage study | Q68082829 | ||
The genes encoding the 5HT1D alpha and 5HT1D beta receptors are unchanged in patients with panic disorder | Q71288378 | ||
Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder | Q71552355 | ||
Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder | Q71607243 | ||
Specificity in familial aggregation of phobic disorders | Q71839840 | ||
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs | Q72081706 | ||
A controlled family study in panic disorder | Q72333374 | ||
A 3-year follow-up of children with and without behavioral inhibition | Q72854521 | ||
Familial transmission of panic disorder: effect of major depression comorbidity | Q73358455 | ||
Panic disorder and social phobia: effects of comorbidity on familial transmission | Q73358548 | ||
Candidate gene study of eight GABAA receptor subunits in panic disorder | Q73565153 | ||
Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder | Q74594100 | ||
Panic and phobic anxiety: defining phenotypes for genetic studies | Q77291361 | ||
Prospects for whole-genome linkage disequilibrium mapping of common disease genes | Q77883184 | ||
Temperament in nonhuman primates | Q92637992 | ||
P433 | issue | 3 | |
P304 | page(s) | 226-235 | |
P577 | publication date | 2001-04-01 | |
P1433 | published in | American Journal of Medical Genetics Part A | Q15755121 |
P1476 | title | Genetic association analysis of behavioral inhibition using candidate loci from mouse models | |
P478 | volume | 105 |
Q24643934 | An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders |
Q36847120 | Anxiety genetics - findings from cross-species genome-wide approaches. |
Q43639148 | Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism |
Q48116089 | Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition |
Q40102780 | Behavioral inhibition |
Q37706695 | DRD4 and striatal modulation of the link between childhood behavioral inhibition and adolescent anxiety |
Q34097713 | Embryonic GABA(B) receptor blockade alters cell migration, adult hypothalamic structure, and anxiety- and depression-like behaviors sex specifically in mice |
Q35104041 | Genetic animal models of anxiety |
Q33923646 | Glutamic acid decarboxylase 65: a link between GABAergic synaptic plasticity in the lateral amygdala and conditioned fear generalization |
Q37618067 | Linkage and association studies of anxiety disorders |
Q34151857 | Neural inhibition enables selection during language processing. |
Q35601495 | Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. |
Q46108975 | Pathologic fear conditioning and anorexia nervosa: on the search for novel paradigms |
Q35316869 | Prioritization and association analysis of murine-derived candidate genes in anxiety-spectrum disorders |
Q34583254 | Role of GABA in anxiety and depression |
Q37223768 | The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders |
Q38838410 | The genetics of anxiety-related negative valence system traits. |
Q30387349 | The nature of individual differences in inhibited temperament and risk for psychiatric disease: A review and meta-analysis. |
Q36917104 | The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders |
Search more.